Obesity Management in Adults With CKD

American Journal of Kidney Diseases

Volumn 53, Issue 1, 2009, Pages 151-165

  Kramer, Holly ^a   Tuttle, Katherine R ^b   Leehey, David ^a   Luke, Amy ^a   Durazo Arvizu, Ramon ^a   Shoham, David ^a   Cooper, Richard ^a   Beddhu, Srinvisan ^c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

bariatric surgery; chronic kidney disease; end stage renal disease; Obesity; weight loss

Indexed keywords

AMFEBUTAMONE; AMFEPRAMONE; AMIODARONE; ANOREXIGENIC AGENT; CALCIUM CARBONATE; CARBONATE DEHYDRATASE INHIBITOR; CYCLOSPORIN; ERYTHROMYCIN; ERYTHROPOIETIN; FLUOXETINE; KETOCONAZOLE; METHYLDOPA; MONOAMINE OXIDASE INHIBITOR; PHENTERMINE; RIMONABANT; SEROTONIN AGONIST; SERTRALINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ANXIETY; ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DEPRESSION; DIALYSIS; DIET THERAPY; DRUG ABSORPTION; DRUG MECHANISM; FAT SOLUBLE VITAMIN DEFICIENCY; FATIGUE; FECES INCONTINENCE; GASTRIC BANDING; HUMAN; HYPERTENSION; INSOMNIA; INTERNAL JUGULAR VEIN; KIDNEY TRANSPLANTATION; LIFESTYLE MODIFICATION; MORTALITY; NAUSEA; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; SIDE EFFECT; SLEEP DISORDER; SOCIAL PSYCHOLOGY; STOMACH BYPASS; SUICIDAL BEHAVIOR; TACHYCARDIA; TREMOR; VEIN CATHETERIZATION; VITAMIN DEFICIENCY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; XEROSTOMIA;

ANTI-OBESITY AGENTS; BARIATRIC SURGERY; CHRONIC DISEASE; DIET THERAPY; FEMALE; HUMANS; KIDNEY DISEASES; OBESITY; WEIGHT LOSS; YOUNG ADULT;

EID: 57649158323     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.10.003     Document Type: Article

References (126)

1. Office of the Surgeon General. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity (2001) Rockville, MD, US Department of Health and Human Services PHS; Washington DC, US Government Printing Office
2. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
3. Wang Y., Chen X., Song Y., Caballero B., and Cheskin L.J. Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int 73 (2008) 19-33
4. Griffin K.A., Kramer H., and Bidani A.K. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 294 (2008) F685-F696
5. Kuczmarski R.J., and Flegal K.M. Criteria for definition of overweight in transition: Background and recommendations for the United States. Am J Clin Nutr 72 (2000) 1074-1081
6. Harvey K.S. Methods for determining healthy body weight in end stage renal disease. J Ren Nutr 16 (2006) 269-276
7. Nutrition and Your Health: Dietary Guidelines for Americans (1995), US Department of Agriculture and US Department of Health and Human Services, Washington DC
8. WHO. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation on Obesity, Geneva, June 3-5, 1997 (1998), World Health Organization, Geneva, Switzerland
9. Durazo-Arvizu R.A., McGee D.L., Cooper R.S., Liao Y., and Luke A. Mortality and optimal body mass index in a sample of the US population. Am J Epidemiol 147 (1998) 739-749
10. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., and Heath Jr. C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 (1999) 1097-1105
11. Andres R., Elahi D., Tobin J.D., Muller D.C., and Brant L. Impact of age on weight goals. Ann Intern Med 103 (1985) 1030-1033
12. Stevens J., Cai J., Pamuk E.R., Williamson D.F., Thun M.J., and Wood J.L. The effect of age on the association between body-mass index and mortality. N Engl J Med 338 (1998) 1-7
13. Grabowski D.C., and Ellis J.E. High body mass index does not predict mortality in older people: Analysis of the Longitudinal Study of Aging. J Am Geriatr Soc 49 (2001) 968-979
14. Stevens J., Cai J., Juhaeri, Thun M.J., Williamson D.F., and Wood J.L. Consequences of the use of different measures of effect to determine the impact of age on the association between obesity and mortality. Am J Epidemiol 150 (1999) 399-407
15. Adams K.F., Schatzkin A., Harris T.B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355 (2006) 763-778
16. Fontaine K.R., Redden D.T., Wang C., Westfall A.O., and Allison D.B. Years of life lost due to obesity. JAMA 289 (2003) 187-193
17. Peeters A., Barendregt J.J., Willekens F., Mackenbach J.P., Al Mamun A., and Bonneux L. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med 138 (2003) 24-32
18. Heiat A., Vaccarino V., and Krumholz H.M. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 161 (2001) 1194-1203
19. Abell J.E., Egan B.M., Wilson P.W., Lipsitz S., Woolson R.F., and Lackland D.T. Differences in cardiovascular disease mortality associated with body mass between black and white persons. Am J Public Health 98 (2008) 63-66
20. Durazo-Arvizu R., Cooper R.S., Luke A., Prewitt T.E., Liao Y., and McGee D.L. Relative weight and mortality in U.S. blacks and whites: Findings from representative national population samples. Ann Epidemiol 7 (1997) 383-395
21. Bigaard J., Frederiksen K., Tjonneland A., et al. Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women. Int J Obes 29 (2005) 778-784
22. Rankinen T., Kim S.Y., Perusse L., Despres J.P., and Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. J Int Assoc Stud Obes 23 (1999) 801-809
23. Reeder B.A., Senthilselvan A., Despres J.P., et al. The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ 157 suppl 1 (1997) S39-S45
24. Pouliot M.C., Despres J.P., Lemieux S., et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73 (1994) 460-468
25. Janssen I., Katzmarzyk P.T., and Ross R. Body mass index, waist circumference, and health risk: Evidence in support of current National Institutes of Health guidelines. Arch Intern Med 162 (2002) 2074-2079
26. Balkau B., Deanfield J.E., Despres J.P., et al. International Day for the Evaluation of Abdominal Obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116 (2007) 1942-1951
27. Lean M.E., Han T.S., and Morrison C.E. Waist circumference as a measure for indicating need for weight management. BMJ 311 (1995) 158-161
28. Narisawa S., Nakamura K., Kato K., Yamada K., Sasaki J., and Yamamoto M. Appropriate waist circumference cutoff values for persons with multiple cardiovascular risk factors in Japan: A large cross-sectional study. J Epidemiol 18 (2008) 37-42
29. Koster A., Leitzmann M.F., Schatzkin A., et al. Waist circumference and mortality. Am J Epidemiol 167 (2008) 1465-1475
30. Zhang C., Rexrode K.M., van Dam R.M., Li T.Y., and Hu F.B. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: Sixteen years of follow-up in US women. Circulation 117 (2008) 1658-1667
31. Chen J., Muntner P., Hamm L.L., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14 (2003) 469-477
32. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
33. Kramer H., Luke A., Bidani A., Cao G., Cooper R., and McGee D. Obesity and prevalent and incident chronic kidney disease: The Hypertension Detection and Follow-up Program. Am J Kidney Dis 46 (2005) 587-594
34. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
35. Gelber R.P., Kurth T., Kausz A.T., et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46 (2005) 871-880
36. Sanches F., Avesani C., Kamimura M., et al. Waist circumference and visceral fat in CKD: A cross-sectional study. Am J Kidney Dis 52 (2008) 66-73
37. Elsayed E.F., Tighiouart H., Weiner D.E., et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis 52 (2008) 49-57
38. Kwan B.C., Murtaugh M.A., and Beddhu S. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. Clin J Am Soc Nephrol 2 (2007) 992-998
39. Madero M., Sarnak M.J., Wang X., et al. Body mass index and mortality in CKD. Am J Kidney Dis 50 (2007) 404-411
40. Leavey S.F., McCullough K., Hecking E., Goodkin D., Port F.K., and Young E.W. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 16 (2001) 2386-2394
41. Fleischmann E., Teal N., Dudley J., May W., Bower J.D., and Salahudeen A.K. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55 (1999) 1560-1567
42. Johansen K.L., Young B., Kaysen G.A., and Chertow G.M. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80 (2004) 324-332
43. Kalantar-Zadeh K., Kopple J.D., Kilpatrick R.D., et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46 (2005) 489-500
44. Kalantar-Zadeh K. Obesity paradox in patients on maintenance dialysis. In: Wolf G. (Ed). Obesity and the Kidney (2006), Karger, Basel, Switzerland 57-69
45. Beddhu S., Pappas L.M., Ramkumar N., and Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14 (2003) 2366-2372
46. Beddhu S. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 17 (2004) 229-232
47. Kakiya R., Shoji T., Tsujimoto Y., et al. Body fat mass and lean mass as predictors of survival in hemodialysis patients [see comment]. Kidney Int 70 (2006) 549-556
48. Kalantar-Zadeh K., Kuwae N., Wu D.Y., et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83 (2006) 202-210
49. Lindsted K.D., and Singh P.N. Body mass and 26-year risk of mortality among women who never smoked: Findings from the Adventist Mortality Study. Am J Epidemiol 146 (1997) 1-11
50. McGee D.L., and Diverse Populations Collaboration. Body mass index and mortality: A meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 15 (2005) 87-97
51. de Mutsert R., Snijder M.B., van der Sman-de Beer F., et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 18 (2007) 967-974
52. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006) 898-918
53. Orchard T.J., Temprosa M., Goldberg R., et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial. Ann Intern Med 142 (2005) 611-619
54. Chagnac A., Weinstein T., Herman M., Hirsh J., Gafter U., and Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14 (2003) 1480-1486
55. Morales E., Valero M.A., Leon M., Hernandez E., and Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 41 (2003) 319-327
56. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Guideline 5: Nutritional management in diabetes and chronic kidney disease. Am J Kidney Dis 49 suppl 2 (2007) S95-S107
57. Snow V., Barry P., Fitterman N., Qaseem A., Weiss K., and Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Pharmacologic and surgical management of obesity in primary care: A clinical practice guideline from the American College of Physicians. Ann Intern Med 142 (2005) 525-531
58. Bagby S.P. Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease?. J Am Soc Nephrol 15 (2004) 2775-2791
59. Bantle J.P., Wylie-Rosett J., Albright A.L., et al. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 31 suppl 1 (2008) S61-S78
60. Kahraman S., Yilmaz R., Akinci D., et al. U-Shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patients. J Ren Nutr 15 (2005) 377-386
61. Odamaki M., Furuya R., Ohkawa S., et al. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 14 (1999) 2427-2432
62. Yamauchi T., Kuno T., Takada H., Nagura Y., Kanmatsuse K., and Takahashi S. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 18 (2003) 1842-1847
63. Lichtenstein A.H., Appel L.J., Brands M., et al., American Heart Association Nutrition Committee. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee [erratum in Circulation 114:e629, 2006]. Circulation 114 (2006) 82-96
64. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39 suppl 1 (2002) S72-S75
65. Axelsson J., Rashid Qureshi A., Suliman M.E., et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80 (2004) 1222-1229
66. Hung C.Y., Chen Y.A., Chou C.C., and Yang C.S. Nutritional and inflammatory markers in the prediction of mortality in Chinese hemodialysis patients. Nephron 100 (2005) c20-c26
67. Yeun J.Y., Levine R.A., Mantadilok V., and Kaysen G.A. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 (2000) 469-476
68. Beddhu S., Ramkumar N., and Samore M.H. The paradox of the "body mass index paradox" in dialysis patients: Associations of adiposity with inflammation. Am J Clin Nutr 82 (2005) 909-910
69. Stenvinkel P., and Lindholm B. Resolved: Being fat is good for dialysis patients: The Godzilla effect: Con. J Am Soc Nephrol 19 (2008) 1062-1064
70. Rabbat C.G., Thorpe K.E., Russell J.D., and Churchill D.N. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 11 (2000) 917-922
71. Wolfe R.A., Ashby V.B., Milford E.L., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341 (1999) 1725-1730
72. Gore J.L., Pham P.T., Danovitch G.M., et al. Obesity and outcome following renal transplantation. Am J Transplant 6 (2006) 357-363
73. Meier-Kriesche H.U., Arndorfer J.A., and Kaplan B. The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 73 (2002) 70-74
74. Jindal R.M., and Zawada Jr. E.T. Obesity and kidney transplantation. Am J Kidney Dis 43 (2004) 943-952
75. Johnson D.W., Isbel N.M., Brown A.M., et al. The effect of obesity on renal transplant outcomes. Transplantation 74 (2002) 675-681
76. Kalil R.S., and Hunsicker L.G. The disadvantage of being fat [comment]. J Am Soc Nephrol 19 (2008) 191-193
77. Chang S.H., Coates P.T., and McDonald S.P. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 84 (2007) 981-987
78. Pelletier S.J., Maraschio M.A., Schaubel D.E., et al. Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transplants (2003) 77-88
79. Glanton C.W., Kao T.C., Cruess D., Agodoa L.Y., and Abbott K.C. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 63 (2003) 647-653
80. Eckel R.H. Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med 358 (2008) 1941-1950
81. Packard D.P., Milton J.E., Shuler L.A., Short R.A., and Tuttle K.R. Implications of chronic kidney disease for dietary treatment in cardiovascular disease. J Ren Nutr 16 (2006) 259-268
82. Moinuddin I., and Leehey D.J. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis 15 (2008) 83-96
83. Patel M.G. The effect of dietary intervention on weight gains after renal transplantation. J Ren Nutr 8 (1998) 137-141
84. Guida B., Trio R., Laccetti R., et al. Role of dietary intervention on metabolic abnormalities and nutritional status after renal transplantation. Nephrol Dial Transplant 22 (2007) 3304-3310
85. Kennedy E.T., Bowman S.A., Spence J.T., Freedman M., and King J. Popular diets: Correlation to health, nutrition, and obesity. J Am Diet Assoc 101 (2001) 411-420
86. Friedman A.N. High-protein diets: Potential effects on the kidney in renal health and disease. Am J Kidney Dis 44 (2004) 950-962
87. Uribarri J., and Tuttle K.R. Advanced glycation end products and nephrotoxicity of high-protein diets. Clin J Am Soc Nephrol 1 (2006) 1293-1299
88. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis 35 suppl 2 (2000) S1-S140
89. Li Z., Maglione M., Tu W., et al. Meta-analysis: Pharmacologic treatment of obesity. Ann Intern Med 142 (2005) 532-546
90. Bray G.A., and Greenway F.L. Pharmacological treatment of the overweight patient. Pharmacol Rev 59 (2007) 151-184
91. FDA. Briefing Document. NDA 21-888 Zimulti (rimonabant) Tablets, 20 mg Sanofi Aventis Advisory Committee 2007. http://www.fda.gov/ohrms/dockets/AC/07/briefing/2007-4306b1-fda-backgrounder.pdf Accessed August 18, 2008
92. Henness S., and Perry C.M. Orlistat: A review of its use in the management of obesity. Drugs 66 (2006) 1625-1656
93. Finer N., James W.P., Kopelman P.G., Lean M.E., and Williams G. One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. J Int Assoc Stud Obes 24 (2000) 306-313
94. Torgerson J.S., Hauptman J., Boldrin M.N., and Sjostrom L. XENical in the prevention of Diabetes in Obese Subjects (XENDOS) Study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27 (2004) 155-161
95. Nagele H., Petersen B., Bonacker U., and Rodiger W. Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient. Eur J Clin Pharmacol 55 (1999) 667-669
96. Zhi J., Moore R., Kanitra L., and Mulligan T.E. Pharmacokinetic evaluation of the possible interaction between selected concomitant medications and orlistat at steady state in healthy subjects. J Clin Pharmacol 42 (2002) 1011-1019
97. Kelley D.E., Kuller L.H., McKolanis T.M., Harper P., Mancino J., and Kalhan S. Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care 27 (2004) 33-40
98. Singh A., Sarkar S.R., Gaber L.W., and Perazella M.A. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor. Am J Kidney Dis 49 (2007) 153-157
99. Phurrough S., Salive M., Brechner R., Tillman K., Harrison S., and O'Connor D. Decision Memo for Bariatric Surgery for the Treatment of Morbid Obesity 2006. http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=160 Accessed November 7, 2008
100. Consensus Development Conference Panel. NIH conference: Gastrointestinal surgery for severe obesity. Ann Intern Med 115 (1991) 956-961
101. Flum D.R., Salem L., Elrod J.A., Dellinger E.P., Cheadle A., and Chan L. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 294 (2005) 1903-1908
102. Bouldin M., Ross L., Sumrall C., Loustalot F., Low A., and Land K. The effect of obesity surgery on obesity comorbidity. Am J Med Sci 331 (2006) 183-193
103. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: A systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
104. Sjostrom L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2693
105. Anderson J., and Konz E. Obesity and disease management: Effects of weight loss on co-morbid conditions. Obes Res 9 suppl 11 (2001) S326-S334
106. Flum D.R., and Dellinger E.P. Impact of gastric bypass operation on survival: A population-based analysis. J Am Coll Surg 199 (2004) 543-551
107. Sjostrom L., Narbro K., Sjostrom C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
108. Eleftheriadis T., Antoniadi G., Liakopoulos V., Kartsios C., and Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20 (2007) 440-451
109. Livingston E.H., and Langert J. The impact of age and Medicare status on bariatric surgical outcomes. Arch Surg 141 (2006) 1115-1120
110. Christou N.V., Sampalis J.S., Liberman M., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240 (2004) 416-423
111. Asplin J.R., and Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 177 (2007) 565-569
112. Nasr S.H., D'Agati V., Said S.M., et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: An underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol (2008) Aug 13 [Epub ahead of print]
113. Sinha M.K., Collazo-Clavell M.L., Rule A., et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 72 (2007) 100-107
114. Nelson W.K., Houghton S.G., Milliner D.S., Lieske J.C., and Sarr M.G. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: Potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 1 (2005) 481-485
115. Bernhardt W.M., Schefold J.C., Weichert W., et al. Amelioration of anemia after kidney transplantation in severe secondary oxalosis. Clin Nephrol 65 (2006) 216-221
116. Thakar C.V., Kharat V., Blanck S., and Leonard A.C. Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol 2 (2007) 426-430
117. Koshy A. Laparoscopic gastric banding surgery performed in obese dialysis patients prior to kidney transplantation. Am J Kidney Dis 52 (2008) e15-e17
118. Soto F.C., Higa-Sansone G., Copley J.B., et al. Renal failure, glomerulonephritis and morbid obesity: Improvement after rapid weight loss following laparoscopic gastric bypass. Obes Surg 15 (2005) 137-140
119. Newcombe V., Blanch A., Slater G.H., Szold A., and Fielding G.A. Laparoscopic adjustable gastric banding prior to renal transplantation. Obes Surg 15 (2005) 567-570
120. Alexander J.W., and Goodman H. Gastric bypass in chronic renal failure and renal transplant. Nutr Clin Pract 22 (2007) 16-21
121. Petry N.M., Barry D., Pietrzak R.H., and Wagner J.A. Overweight and obesity are associated with psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med 70 (2008) 288-297
122. Schowalter M., Benecke A., Lager C., et al. Changes in depression following gastric banding: A 5- to 7-year prospective study. Obes Surg 18 (2008) 314-320
123. Onyike C.U., Crum R.M., Lee H.B., Lyketsos C.G., and Eaton W.W. Is obesity associated with major depression?. Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 158 (2003) 1139-1147
124. Wadden T.A., Sarwer D.B., Fabricatore A.N., Jones L., Stack R., and Williams N.S. Psychosocial and behavioral status of patients undergoing bariatric surgery: What to expect before and after surgery. Med Clin North Am 91 (2007) 451-469
125. Dixon J.B., Dixon M.E., and O'Brien P.E. Depression in association with severe obesity: Changes with weight loss. Arch Intern Med 163 (2003) 2058-2065
126. Emery C.F., Fondow M.D., Schneider C.M., et al. Gastric bypass surgery is associated with reduced inflammation and less depression: A preliminary investigation. Obes Surg 17 (2007) 759-763